FDA Criteria: Biosimilar Approval, Manufacturing, & Naming
Upon completion of the activity, participants should be able to explain the data package required by the FDA for biosimilar approval and explain how this differs from a biologic ‘standalone’ development program.
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.